Assignee

ARVINAS OPERATIONS INC

US·59 granted patents·55 pending applications·135 citations·filing 2017–2025

Technology mixA61K109 C07D104 A61P94 C07K22 C12N6 C07B5

Top patents by PatentIndex Score

114 records

0198US11883393B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Jan 30, 2024·5 cites·4 claims
0298US11236051B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Feb 1, 2022·9 cites·3 claims
0398US11104666B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Aug 31, 2021·18 cites·15 claims
0498US10899742B1Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Jan 26, 2021·18 cites·25 claims
0598US10844021B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Nov 24, 2020·13 cites·25 claims
0697US11952347B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2021·Granted Apr 9, 2024·3 cites·7 claims
0797US11597720B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2020·Granted Mar 7, 2023·4 cites·48 claims
0895US12077509B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2023·Granted Sep 3, 2024·1 cites·4 claims
0995US12053469B2Indazole based compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Granted Aug 6, 2024·6 cites·6 claims
1095US11981683B2Indazole based compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Granted May 14, 2024·5 cites·2 claims
1192US11964945B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Apr 23, 2024·2 cites·26 claims
1292US11173211B2Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptidesARVINAS OPERATIONS INC·Filed 2019·Granted Nov 16, 2021·6 cites·25 claims
1392US11065231B2Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptidesARVINAS OPERATIONS INC·Filed 2018·Granted Jul 20, 2021·16 cites·24 claims
1491US12036209B2Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptidesARVINAS OPERATIONS INC·Filed 2021·Granted Jul 16, 2024·2 cites·3 claims
1591US11384063B2Modulators of estrogen receptor proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2020·Granted Jul 12, 2022·2 cites·8 claims
1690US11858940B2Selective modulators of mutant LRRK2 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Granted Jan 2, 2024·2 cites·12 claims
1790US2025320195A1Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
1889US11986532B2Modulators of BCL6 proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2022·Granted May 21, 2024·1 cites·4 claims
1989US11191741B2Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptideARVINAS OPERATIONS INC·Filed 2017·Granted Dec 7, 2021·3 cites·13 claims
2089US11161841B2Modulators of proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2019·Granted Nov 2, 2021·3 cites·22 claims
2189US2025034096A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
2287US12043612B2Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the sameARVINAS OPERATIONS INC·Filed 2021·Granted Jul 23, 2024·3 cites·12 claims
2387US11912699B2Tau-protein targeting compounds and associatedARVINAS OPERATIONS INC·Filed 2020·Granted Feb 27, 2024·2 cites·21 claims
2486US10994015B2EGFR proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2017·Granted May 4, 2021·3 cites·25 claims
2585US12427144B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2023·Granted Sep 30, 2025·0 cites·16 claims
2685US11707452B2Modulators of alpha-synuclein proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2019·Granted Jul 25, 2023·2 cites·19 claims
2785US11427548B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Aug 30, 2022·2 cites·15 claims
2885US2025228944A1Compounds and methods for the targeted degradation of bromodomain-containing proteinsARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
2984US12156916B2Rapid accelerated fibrosarcoma (RAF) degrading compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2023·Granted Dec 3, 2024·0 cites·9 claims
3084US11957759B1Rapidly accelerated fibrosarcoma (RAF) degrading compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2023·Granted Apr 16, 2024·0 cites·6 claims
3184US11512083B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Nov 29, 2022·1 cites·17 claims
3284US2024076281A1Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
3383US2026053796A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
3482US2025223265A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
3581US10865202B2Indole derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2019·Granted Dec 15, 2020·1 cites·20 claims
3681US2025161465A1Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
3780US12171831B2Compounds and methods for the targeted degradation of bromodomain- containing proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Dec 24, 2024·0 cites·14 claims
3879US12441708B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
3979US12239711B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Mar 4, 2025·0 cites·1 claims
4079US2024382599A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
4178US12264157B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Apr 1, 2025·0 cites·24 claims
4278US12172981B2Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degradersARVINAS OPERATIONS INC·Filed 2021·Granted Dec 24, 2024·0 cites·18 claims
4378US10806737B2Compounds and methods for the targeted degradation of fetal liver kinase polypeptidesARVINAS OPERATIONS INC·Filed 2017·Granted Oct 20, 2020·2 cites·23 claims
4478US2025313547A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
4578US2026022117A1Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
4677US2025360219A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
4776US2024059686A1Compounds and methods for the targeted degradation of the androgen receptorARVINAS OPERATIONS INC·Filed 2022·Application pending·0 cites
4875US12559506B2Indazole based compounds and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Granted Feb 24, 2026·0 cites·20 claims
4974US12496301B2Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophyARVINAS OPERATIONS INC·Filed 2024·Granted Dec 16, 2025·0 cites·30 claims
5074US2024299366A1Imide-based modulators of proteolysis and associated methods of useARVINAS OPERATIONS INC·Filed 2023·Application pending·0 cites

Showing the top 50 of 114 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when ARVINAS OPERATIONS INC files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →